Evidence map›Paper›PMID 27274214›Full record

ArticleClinical interventions in aging2016

Does severity of dermatochalasis in aging affect corneal biomechanical properties?

Kurşat Atalay, Ceren Gurez, Ahmet Kirgiz, Kubra Serefoglu Cabuk

Abstract read
In one paragraph

Article in Clinical interventions in aging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kurşat AtalayDepartment of Ophthalmology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Ceren GurezDepartment of Ophthalmology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Ahmet KirgizDepartment of Ophthalmology, Bagcilar Training and Research Hospital, Istanbul, Turkey.
Kubra Serefoglu CabukDepartment of Ophthalmology, Bagcilar Training and Research Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to investigate the possibility of a relationship between corneal biomechanical properties and different grades of dermatochalasis. PATIENTS AND

methodsPatients were assigned to four groups according to the severity of their dermatochalasis: normal (Group 1), mild (Group 2), moderate (Group 3), and severe (Group 4). An Ocular Response Analyzer device was used to measure corneal hysteresis (CH), corneal resistance factor (CRF), and corneal-compensated intraocular pressure (IOPcc).

resultsWe found no significant differences in the mean values of the CH, CRF, and IOPcc of all groups (P=0.75, P=0.93, and P=0.11, respectively). However, CH and IOPcc were negatively correlated in Group 1, Group 2, and Group 3 patients (P=0.013, r=-0.49; P=0.015, r=-0.52; and P=0.011, r=-0.47, respectively), but this correlation was not apparent in the Group 4 patients (P=0.57, r=0.12). CRF and IOPcc were correlated, but only in Group 4 (P=0.001, r=0.66).

conclusionSevere dermatochalasis was associated with altered corneal biomechanical properties. Some of the important visual consequences of dermatochalasis and related diseases (such as floppy eyelid syndrome) can be understood by considering corneal biomechanical alterations.

Indexed as

AgingIntraocular PressureAdultAgedBiomechanical PhenomenaCorneaCross-Sectional StudiesEyelid DiseasesFemaleHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexTonometry, OcularTurkeycorneacorneal biomechanical propertiescorneal hysteresiscorneal resistance factordermatochalasis

Identifiers

PMID27274214
PMCPMC4876690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.